博駿教育(01758.HK)附屬及新登記股東等訂立新結構性合約
格隆匯6月19日丨博駿教育(01758.HK)公佈,於2020年6月19日,公司全資附屬成都博駿、新登記股東、綜合聯屬實體及中國營辦學校的董事及理事會成員按與現有結構性合約相同的條款及條件訂立新結構性合約,主要由於成都銘賢的名義股東由現有登記股東(為個人)變更為新登記股東(為公司實體)。現有結構性合約於2020年6月16日由新結構性合約取代。
訂立新結構性合約旨在以新登記股東(為公司實體)作為成都銘賢的唯一名義股東,減少日後成都銘賢的名義個人股東出現任何變動時重新訂立新系列合約安排的可能性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.